Trials / Completed
CompletedNCT01956123
Evidence-based Stimulation Trial With Human rFSH in Europe and Rest of World 2
A Controlled, Assessor-blind, Parallel Groups, Multicentre, Multinational Trial Evaluating the Immunogenicity of FE 999049 in Repeated Cycles of Controlled Ovarian Stimulation in Women Undergoing an Assisted Reproductive Technology Programme
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 513 (actual)
- Sponsor
- Ferring Pharmaceuticals · Industry
- Sex
- Female
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Not accepted
Summary
This trial investigates the immunogenicity of FE 999049 in repeated cycles.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Follitropin Delta (FE 999049) | |
| DRUG | Follitropin Alfa (GONAL-F) |
Timeline
- Start date
- 2014-03-26
- Primary completion
- 2015-05-01
- Completion
- 2017-01-03
- First posted
- 2013-10-08
- Last updated
- 2023-09-06
- Results posted
- 2018-09-21
Locations
13 sites across 11 countries: Belgium, Brazil, Canada, Czechia, Denmark, France, Italy, Poland, Russia, Spain, United Kingdom
Source: ClinicalTrials.gov record NCT01956123. Inclusion in this directory is not an endorsement.